When Signifor LAR was approved in 2014, Novartis was suggesting it could become a replacement for its blockbuster Sandostatin LAR (octreotide acetate) depot product, which was making annual sales ...

Teva Pharma Industries Ltd ADR, Allergan PLC, Johnson & Johnson, CVS Health Corp. Read MarketBeat.com (Jea Yu)'s latest article on Investing.com ...

The micro-sphere technology has previously been applied to Lupron Depot (TAP Pharmaceuticals), Nutropin Depot (Genentech), and Sandostatin LAR (Novartis). With hydrolysis, the polymer gradually ...

Diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated poliovirus vaccine combined Pediarix (GlaxoSmithKline) 24 hr Manufacturer Diphtheria and ...